Are Dietary and Serum Advanced Glycation End Products (AGEs) Potential Contributors to Inflammation in Women with Polycystic Ovary Syndrome?

dc.contributor.authorYurt, Merve
dc.contributor.authorGokmen-Ozel, Hulya
dc.date.accessioned2026-02-06T18:24:13Z
dc.date.issued2025
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractBackground/Objectives: Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by metabolic and hormonal imbalances in women of reproductive age. Various studies have emphasized that a diet high in advanced glycation end products (AGEs) and high serum AGE levels may be associated with reproductive and metabolic dysfunction in PCOS. Recently, the role played by dietary and serum AGE levels in the pathogenesis of PCOS was emphasized. Methods: In this study, we investigated the relationships between dietary AGE intake and serum AGE levels, some metabolic parameters, and anthropometric measurements in individuals with PCOS and a control group of women without PCOS. A total of 87 women with PCOS (n = 43) and without PCOS (n = 44) of a similar age and with a similar body mass index were included in this study. We analyzed dietary AGE intake, serum AGE (CML, sRAGE, and MGO) levels, and markers of inflammation (TNF-alpha and hs-CRP). Results: The daily dietary AGE intake in the PCOS group (13,191.05 +/- 3360.12 kU/day) was higher than that in the control group (11,740.28 +/- 2940.61 kU/day) (p = 0.035). The serum CML/sRAGE ratio was found to be higher in the PCOS group (413.94 +/- 1114.79) than in the control group (143.24 +/- 124.71) (p = 0.002). The cut-off points for dietary AGE intake, serum CML, and the CML/sRAGE ratio levels, which may be associated with the risk of PCOS development, were determined to be 11,359.06 kU/day, 417.50 ng/mL, and 140.91 ng/mL, respectively. Conclusions: Regular monitoring of serum AGE levels may reduce the health risks associated with PCOS. Moreover, to reduce dietary AGE intake in patients with PCOS, we recommend using steaming, boiling, poaching, or simmering with minimal water instead of dry-heat cooking methods.
dc.identifier.doi10.3390/jcm14165803
dc.identifier.issn2077-0383
dc.identifier.issue16
dc.identifier.orcid0000-0002-8282-6468
dc.identifier.orcid0000-0003-2164-8693
dc.identifier.pmid40869631
dc.identifier.scopus2-s2.0-105014407243
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/jcm14165803
dc.identifier.urihttps://hdl.handle.net/11129/10078
dc.identifier.volume14
dc.identifier.wosWOS:001557800000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofJournal of Clinical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260204
dc.subjectpolycystic ovary syndrome
dc.subjectadvanced glycation end products (AGEs)
dc.subjectdietary AGEs
dc.subjectbiochemical parameters
dc.subjectcarboxymethyl lysine
dc.subjectsoluble receptor for advanced glycation end products
dc.subjectmethylglyoxal
dc.titleAre Dietary and Serum Advanced Glycation End Products (AGEs) Potential Contributors to Inflammation in Women with Polycystic Ovary Syndrome?
dc.typeArticle

Files